SCHEMBL21649535

SCHEMBL21649535

Cc1ccncc1CN(C)C=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 4/20 0.37
▸ SLC6A2 P23975 2/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ SIRT3 Q9NTG7 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ GABRA1 P14867 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ CHRNB2 P17787 2/20 0.35
▸ CHRNA4 P43681 2/20 0.35
▸ SOST Q9BQB4 1/20 0.34
▸ ADAMTS4 O75173 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ ADAMTS5 Q9UNA0 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CYP2C9 P11712 3/20 0.33
▸ NAMPT P43490 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8149064 0.80 SLC6A4 (0.51) SLC6A4SLC6A2SLC6A3CYP11B1CYP11B2
SCHEMBL12548100 0.78 CHRNB2 (0.52) SLC6A4SLC6A2SLC6A3CYP11B1CYP11B2
SCHEMBL24135046 0.77 CHRNB2 (0.42) SLC6A4SLC6A2SLC6A3CYP11B1CYP11B2
SCHEMBL3976911 0.74 SIRT3 (0.40) CYP11B1CYP11B2SIRT3TDP1GABRA1
SCHEMBL4310308 0.74 MAPT (0.46) —
SCHEMBL212818 0.73 — —
SCHEMBL30335585 0.73 — —
SCHEMBL5513954 0.72 MMP13 (0.39) MMP13HTTCYP2C9CYP1A2CYP3A4
SCHEMBL31336994 0.71 NOS1 (0.39) CYP11B1CYP11B2SIRT3TDP1GABRA1
SCHEMBL23580328 0.71 NOS1 (0.39) CYP11B1CYP11B2SIRT3TDP1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023851-A1 BIFUNCTIONAL SUBSTITUED PYRIMIDINES AS MODULATORS OF FAK PROTEOLYSE YALE UNIVERSITY (US) 2020-01-30 — — WO disclosed
Send feedback